Copyright Reports & Markets. All rights reserved.

Global Drug Eluting Balloons (DEBs) Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Drug Eluting Balloons (DEBs) Market Overview

      • 1.1 Product Overview and Scope of Drug Eluting Balloons (DEBs)
      • 1.2 Drug Eluting Balloons (DEBs) Segment by Type
        • 1.2.1 Global Drug Eluting Balloons (DEBs) Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Peripheral DEBs
        • 1.2.3 Coronary DEBs
      • 1.3 Drug Eluting Balloons (DEBs) Segment by Application
        • 1.3.1 Drug Eluting Balloons (DEBs) Consumption Comparison by Application (2014-2025)
        • 1.3.2 Cath labs
        • 1.3.3 Hospitals
        • 1.3.4 Ambulatory surgical centers (ASCs)
      • 1.4 Global Drug Eluting Balloons (DEBs) Market by Region
        • 1.4.1 Global Drug Eluting Balloons (DEBs) Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Drug Eluting Balloons (DEBs) Market Size
        • 1.5.1 Global Drug Eluting Balloons (DEBs) Revenue (2014-2025)
        • 1.5.2 Global Drug Eluting Balloons (DEBs) Production (2014-2025)

      2 Global Drug Eluting Balloons (DEBs) Market Competition by Manufacturers

      • 2.1 Global Drug Eluting Balloons (DEBs) Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Drug Eluting Balloons (DEBs) Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Drug Eluting Balloons (DEBs) Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Drug Eluting Balloons (DEBs) Production Sites, Area Served, Product Types
      • 2.5 Drug Eluting Balloons (DEBs) Market Competitive Situation and Trends
        • 2.5.1 Drug Eluting Balloons (DEBs) Market Concentration Rate
        • 2.5.2 Drug Eluting Balloons (DEBs) Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Drug Eluting Balloons (DEBs) Production Market Share by Regions

      • 3.1 Global Drug Eluting Balloons (DEBs) Production Market Share by Regions
      • 3.2 Global Drug Eluting Balloons (DEBs) Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Drug Eluting Balloons (DEBs) Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Drug Eluting Balloons (DEBs) Production
        • 3.4.1 North America Drug Eluting Balloons (DEBs) Production Growth Rate (2014-2019)
        • 3.4.2 North America Drug Eluting Balloons (DEBs) Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Drug Eluting Balloons (DEBs) Production
        • 3.5.1 Europe Drug Eluting Balloons (DEBs) Production Growth Rate (2014-2019)
        • 3.5.2 Europe Drug Eluting Balloons (DEBs) Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Drug Eluting Balloons (DEBs) Production (2014-2019)
        • 3.6.1 China Drug Eluting Balloons (DEBs) Production Growth Rate (2014-2019)
        • 3.6.2 China Drug Eluting Balloons (DEBs) Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Drug Eluting Balloons (DEBs) Production (2014-2019)
        • 3.7.1 Japan Drug Eluting Balloons (DEBs) Production Growth Rate (2014-2019)
        • 3.7.2 Japan Drug Eluting Balloons (DEBs) Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Drug Eluting Balloons (DEBs) Consumption by Regions

      • 4.1 Global Drug Eluting Balloons (DEBs) Consumption by Regions
      • 4.2 North America Drug Eluting Balloons (DEBs) Consumption (2014-2019)
      • 4.3 Europe Drug Eluting Balloons (DEBs) Consumption (2014-2019)
      • 4.4 China Drug Eluting Balloons (DEBs) Consumption (2014-2019)
      • 4.5 Japan Drug Eluting Balloons (DEBs) Consumption (2014-2019)

      5 Global Drug Eluting Balloons (DEBs) Production, Revenue, Price Trend by Type

      • 5.1 Global Drug Eluting Balloons (DEBs) Production Market Share by Type (2014-2019)
      • 5.2 Global Drug Eluting Balloons (DEBs) Revenue Market Share by Type (2014-2019)
      • 5.3 Global Drug Eluting Balloons (DEBs) Price by Type (2014-2019)
      • 5.4 Global Drug Eluting Balloons (DEBs) Production Growth by Type (2014-2019)

      6 Global Drug Eluting Balloons (DEBs) Market Analysis by Applications

      • 6.1 Global Drug Eluting Balloons (DEBs) Consumption Market Share by Application (2014-2019)
      • 6.2 Global Drug Eluting Balloons (DEBs) Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Drug Eluting Balloons (DEBs) Business

      • 7.1 B. Braun Melsungen
        • 7.1.1 B. Braun Melsungen Drug Eluting Balloons (DEBs) Production Sites and Area Served
        • 7.1.2 Drug Eluting Balloons (DEBs) Product Introduction, Application and Specification
        • 7.1.3 B. Braun Melsungen Drug Eluting Balloons (DEBs) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Cook Medical
        • 7.2.1 Cook Medical Drug Eluting Balloons (DEBs) Production Sites and Area Served
        • 7.2.2 Drug Eluting Balloons (DEBs) Product Introduction, Application and Specification
        • 7.2.3 Cook Medical Drug Eluting Balloons (DEBs) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 C.R. Bard
        • 7.3.1 C.R. Bard Drug Eluting Balloons (DEBs) Production Sites and Area Served
        • 7.3.2 Drug Eluting Balloons (DEBs) Product Introduction, Application and Specification
        • 7.3.3 C.R. Bard Drug Eluting Balloons (DEBs) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Eurocor
        • 7.4.1 Eurocor Drug Eluting Balloons (DEBs) Production Sites and Area Served
        • 7.4.2 Drug Eluting Balloons (DEBs) Product Introduction, Application and Specification
        • 7.4.3 Eurocor Drug Eluting Balloons (DEBs) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Medtronic
        • 7.5.1 Medtronic Drug Eluting Balloons (DEBs) Production Sites and Area Served
        • 7.5.2 Drug Eluting Balloons (DEBs) Product Introduction, Application and Specification
        • 7.5.3 Medtronic Drug Eluting Balloons (DEBs) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Aachen Resonance
        • 7.6.1 Aachen Resonance Drug Eluting Balloons (DEBs) Production Sites and Area Served
        • 7.6.2 Drug Eluting Balloons (DEBs) Product Introduction, Application and Specification
        • 7.6.3 Aachen Resonance Drug Eluting Balloons (DEBs) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Acrostak
        • 7.7.1 Acrostak Drug Eluting Balloons (DEBs) Production Sites and Area Served
        • 7.7.2 Drug Eluting Balloons (DEBs) Product Introduction, Application and Specification
        • 7.7.3 Acrostak Drug Eluting Balloons (DEBs) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Cardionovum
        • 7.8.1 Cardionovum Drug Eluting Balloons (DEBs) Production Sites and Area Served
        • 7.8.2 Drug Eluting Balloons (DEBs) Product Introduction, Application and Specification
        • 7.8.3 Cardionovum Drug Eluting Balloons (DEBs) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Spectranetics
        • 7.9.1 Spectranetics Drug Eluting Balloons (DEBs) Production Sites and Area Served
        • 7.9.2 Drug Eluting Balloons (DEBs) Product Introduction, Application and Specification
        • 7.9.3 Spectranetics Drug Eluting Balloons (DEBs) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served

      8 Drug Eluting Balloons (DEBs) Manufacturing Cost Analysis

      • 8.1 Drug Eluting Balloons (DEBs) Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Drug Eluting Balloons (DEBs)
      • 8.4 Drug Eluting Balloons (DEBs) Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Drug Eluting Balloons (DEBs) Distributors List
      • 9.3 Drug Eluting Balloons (DEBs) Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Drug Eluting Balloons (DEBs) Market Forecast

      • 11.1 Global Drug Eluting Balloons (DEBs) Production, Revenue Forecast
        • 11.1.1 Global Drug Eluting Balloons (DEBs) Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Drug Eluting Balloons (DEBs) Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Drug Eluting Balloons (DEBs) Price and Trend Forecast (2019-2025)
      • 11.2 Global Drug Eluting Balloons (DEBs) Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Drug Eluting Balloons (DEBs) Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Drug Eluting Balloons (DEBs) Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Drug Eluting Balloons (DEBs) Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Drug Eluting Balloons (DEBs) Production, Revenue Forecast (2019-2025)
      • 11.3 Global Drug Eluting Balloons (DEBs) Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Drug Eluting Balloons (DEBs) Consumption Forecast (2019-2025)
        • 11.3.2 Europe Drug Eluting Balloons (DEBs) Consumption Forecast (2019-2025)
        • 11.3.3 China Drug Eluting Balloons (DEBs) Consumption Forecast (2019-2025)
        • 11.3.4 Japan Drug Eluting Balloons (DEBs) Consumption Forecast (2019-2025)
      • 11.4 Global Drug Eluting Balloons (DEBs) Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Drug Eluting Balloons (DEBs) Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        A DEB, also known as a drug-coated balloon (DCB), is an advanced technology used in the treatment of coronary and peripheral arterial diseases. These diseases cause narrowing of arteries leading to blockages. A DEB is used along with paclitaxel, an anti-proliferative drug, which helps in removing plaque from the walls of arteries and widening them. DEBs are primarily used in the treatment of two types of diseases: Peripheral arterial diseases (PADs), and Coronary arterial diseases (CADs).
        Open heart surgeries and open peripheral surgeries can be life-threating as they involve several complications. This is compelling surgeons to adopt MI techniques over traditional techniques since they ensure high accuracy, faster recovery, fewer post-surgery infections, reduced hospital stays and incision marks, and minimal complications. This will increase the demand for DEBs since they enhance surgical precision by providing a 3D view of the patient and allows the insertion of DEBs in an individual's body by enabling the manipulation of small surgical tools.
        The DEBs market is characterized by the presence of several players. Vendors are coming up with various advanced technologies such as IN.PACT Admiral, Lutonix 035, SeQuent Please Neo, Elutax SV, Freeway, Advance 18 PTX and DIOR. This will drive the demand for DEBs and increase the sales volume and profit margins of vendors. The availability of a substantial number of CE approved DEB products, an increase in the number of clinical trials, and the approval of certain DEB products by the US FDA, will offer significant growth opportunities to the vendors.

        The global Drug Eluting Balloons (DEBs) market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Drug Eluting Balloons (DEBs) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Drug Eluting Balloons (DEBs) market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        B. Braun Melsungen
        Cook Medical
        C.R. Bard
        Eurocor
        Medtronic
        Aachen Resonance
        Acrostak
        Cardionovum
        Spectranetics

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Peripheral DEBs
        Coronary DEBs

        Segment by Application
        Cath labs
        Hospitals
        Ambulatory surgical centers (ASCs)

        Buy now